Boshinti Tablet 20 Milligrams (Bonoatrazan Fumarate)

Adult dose

⚫ Gastric ulcer Administer vonoprazan 20mg orally once daily to adults. For gastric ulcers, treatment is generally given for up to 8 weeks. ⚫ Treatment of erosive gastroesophageal reflux disease and maintenance therapy after treatment Administer vonoprazan 20mg orally once daily to adults for up to 4 weeks. If the effect is insufficient, treatment may be continued for up to 8 weeks. For maintenance therapy after treatment of erosive gastroesophageal reflux disease, administer 10mg orally once daily; if the effect is insufficient, 20mg may be administered orally once daily. ⚫ Prevention of recurrence of gastric or duodenal ulcers during administration of nonsteroidal anti-inflammatory drugs (NSAIDs) Administer vonoprazan 10mg orally once daily to adults.

This medication should not be used in patients who have had hypersensitivity reactions to this drug or its components. Additionally, it should not be administered to patients currently taking certain antiviral agents such as atazanavir, nelfinavir, or rilpivirine. Patients with impaired liver function or decreased kidney function should use this drug with caution as metabolism and excretion of the medication may be delayed, leading to elevated blood concentrations. Elderly patients may have reduced physiological functions, requiring careful use. Gastrointestinal symptoms such as constipation, diarrhea, abdominal bloating, and nausea may occur while taking this medication, and rarely, hypersensitivity reactions such as rashes or signs of liver dysfunction may occur. If any adverse reactions occur, consult a doctor immediately and discontinue the medication if necessary. Since abnormal liver function has been reported, regular liver function tests are necessary, and it's important to discontinue use immediately if any signs of liver damage appear. It is important to regularly monitor the condition through endoscopy or other evaluations if this medication is taken for a prolonged period. Patients with a history of gastric ulcers or duodenal ulcers should confirm their medical history before using this drug and should use it only if maintenance therapy is required. This medication inhibits gastric acid secretion and can affect the absorption of other medications, so caution is needed as effects may be reduced or side effects may increase when used in combination with certain drugs. Long-term or high-dose use may increase the risk of osteoporotic fractures, so it's advisable to check bone health. Pregnant or breastfeeding individuals should ideally not use this medication unless in special circumstances since safety has not been established; breastfeeding should be discontinued if the drug is taken while nursing. The safety in children or newborns has not been established, so its use should be avoided in these populations. Finally, this medication should be taken directly from the packaged sheet, ensuring that the sheet itself is not swallowed, as it may damage the esophagus and cause serious complications.

• Constipation
• diarrhea
• abdominal distension
• nausea
• rash
• elevation of AST (GOT)
• elevation of ALT (GPT)
• elevation of AL-P
• elevation of LDH
• elevation of γ-GTP

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, preferably at room temperature between 1°C and 30°C. This ensures that the drug's efficacy is maintained and can be used safely.

Appearance

Light red oval film-coated tablet

Package unit

100 tablets (10 tablets/PTP packaging x 10 packs)/box 30 tablets (10 tablets/PTP packaging x 3 packs)/box